Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CONDUIT PHARMACEUTICALS INC. | Director | Stock Option (Right to Buy) | 0 | $0 | $5.51 | May 13, 2024 | Direct |
Codex DNA, Inc. | Chief Financial Officer | Stock Option (right to buy) | 107K | Feb 27, 2022 | Direct | ||
Codex DNA, Inc. | Chief Financial Officer | Restricted Stock Unit | 28K | Feb 27, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CDT | CONDUIT PHARMACEUTICALS INC. | May 13, 2024 | 1 | -$358K | 4 | May 15, 2024 | Director |
CDT | CONDUIT PHARMACEUTICALS INC. | Dec 1, 2023 | 1 | $358K | 4 | Dec 5, 2023 | Director |
MURF | CONDUIT PHARMACEUTICALS INC. | Sep 22, 2023 | 0 | $0 | 3 | Sep 26, 2023 | Director |
TBIO | Codex DNA, Inc. | Feb 27, 2022 | 2 | $0 | 4 | Mar 1, 2022 | Chief Financial Officer |
TBIO | Codex DNA, Inc. | Jun 17, 2021 | 0 | $0 | 3 | Jun 17, 2021 | Chief Financial Officer |